Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

31/10/2022 06:00

Oct 31 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.35               7.96             24.00    
                 (+30.0 pct)         (+13.7 pct)      (+35.2 pct) 
  Operating          2.31               1.97              5.26    
                 (+17.5 pct)         (+69.6 pct)      (+25.4 pct) 
  Recurring          5.93               2.53              9.80    
                (+134.4 pct)         (+93.8 pct)      (+38.5 pct) 
  Net                4.42               3.50              7.00    
                 (+26.1 pct)        (+207.5 pct)      (-1.8 pct)  
  EPS            106.16 yen           84.15 yen       168.13 yen  
  Ann Div                             40.00 yen        40.00 yen  
  -Q2 div         20.00 yen              NIL                      
  -Q4 div                             40.00 yen        20.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T